Utility of Next-Generation Sequencing in the Reconstruction of Clonal Architecture in a Patient with an EGFR Mutated Advanced Non-Small Cell Lung Cancer: A Case Report

EGFR tyrosine kinase inhibitors (EGFR-TKIs) have revolutionized the treatment of non-small cell lung cancer (NSCLC) patients with activating EGFR mutations. However, targeted therapies impose a strong selective pressure against the coexisting tumor populations that lead to the emergence of resistant...

Descripción completa

Detalles Bibliográficos
Autores principales: Simarro, Javier, Pérez-Simó, Gema, Mancheño, Nuria, Muñoz-Núñez, Carlos Francisco, Cases, Enrique, Juan, Óscar, Palanca, Sarai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9141594/
https://www.ncbi.nlm.nih.gov/pubmed/35626421
http://dx.doi.org/10.3390/diagnostics12051266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9141594/
https://www.ncbi.nlm.nih.gov/pubmed/35626421
http://dx.doi.org/10.3390/diagnostics12051266

Ejemplares similares